Ovarian Cancer Follow-up: A Preliminary Comparison of 2 Approaches

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Anne LanceleyIan Jacobs

Abstract

The aim of the study was to perform a preliminary comparison of quality of life (QoL) and patient satisfaction in individualized nurse-led follow-up versus conventional medical follow-up in ovarian cancer. One hundred twelve women who received a diagnosis of ovarian, fallopian tube, or peritoneal cancer, completed primary treatment by surgery alone or with chemotherapy, irrespective of outcome with regard to remission, and expected survival of more than 3 months. Fifty-seven participants were randomized to individualized follow-up and 55 patients to conventional follow-up. Well-being was measured at baseline and at 3, 6, 12, and 24 months after randomization for QoL (QLQ-C30 [European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire], QLQ-Ov28), the Hospital Anxiety and Depression Scale (HADS), and a Patient Satisfaction Questionnaire (PSQ-III). The primary endpoints were the effects of follow-up on each of the scores (via hierarchical mixed-effects model) and on relapse-free time (via Cox model). The total cost of follow-up was compared between each group. There was evidence for a QoL and patient satisfaction benefit for individualized versus standard follow-up (QLQ-C30, P = 0.013; 95% confi...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Feb 17, 2001·Psycho-oncology·J Brennan
Jan 31, 2003·Cancer Nursing·Doris HowellKaren A Deane
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E GreimelUNKNOWN EORTC Quality of Life Group and the Quality of Life Unit
Oct 29, 2004·Journal of Health Services Research & Policy·Julie Barber, Simon Thompson
Oct 26, 2005·Patient Education and Counseling·Cathy HeavenPeter Maguire
May 9, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S AebiUNKNOWN ESMO Guidelines Working Group
Oct 1, 2008·BMJ : British Medical Journal·Peter CraigUNKNOWN Medical Research Council Guidance
Dec 27, 2008·Patient Education and Counseling·Lisa Kennedy SheldonKrista Rinaldi
Jun 19, 2009·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Anne LydonJulie Wray
Jan 9, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Michael FriedlanderMadeline King
Oct 5, 2010·Lancet·Gordon J S RustinUNKNOWN EORTC 55955 investigators
Dec 8, 2010·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Howard LeventhalJessica Y Breland
Oct 29, 2011·British Journal of Cancer·M MistryP Sasieni
Jan 22, 2013·The Lancet Oncology·Laura J Havrilesky, Amy P Abernethy
Jul 26, 2013·BMJ Open·Simon LeesonRhiannon Whitaker

❮ Previous
Next ❯

Citations

May 3, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N ColomboUNKNOWN ESMO–ESGO Ovarian Cancer Consensus Conference Working Group
Nov 22, 2019·The Cochrane Database of Systematic Reviews·Beverley L HøegChristoffer Johansen
Apr 5, 2018·BMC Cancer·Matthew SchlumbrechtDiane Bodurka
Sep 6, 2020·European Journal of Cancer Care·Siew-Fei NguKaren K L Chan
Sep 13, 2018·Current Oncology Reports·Lynn BuckleySarah Bolton
May 3, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO-ESGO Ovarian Cancer Consensus Conference Working Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Anne LanceleyIan Jacobs
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
K CocksJulia M Brown
© 2022 Meta ULC. All rights reserved